iSERA Lifesciences LimitedBSE: COVIDH

Isera Lifesciences Limited Press Release Oct 01 2026

· Issued by iSERA Lifesciences Limited via BSE India

Filed with BSE · · 21 pages · English

Summary by 6ix AI

The board approved the allotment of equity shares on a preferential basis through a share swap with shareholders of iSERA Biological Limited. The shares will rank equally with existing shares and were allotted in dematerialized form.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

The Board of Directors of the Company, at its meeting held today i.e. October 01, 2026, has approved the allotment of 1,61,82,800 (One Crore Sixty-One Lakh Eighty-Two Thousand Eight Hundred) fully paid-up equity shares of face value of Rs. 10/- (Rupees Ten only) each at an issue price of Rs. 48.20/- (Rupees Forty-Eight and Paise Twenty only) per share [including a share premium of Rs. 38.20/- (Rupees Thirty-Eight and Paise Twenty only) per share] on a preferential basis by way of Share Swap at a ratio of 1:1 (i.e. one equity share of the Company for every one equity share of iSERA Biological Limited held by the allottee), to the following allottees belonging to the Promoter and Non-Promoter categories.

iSERA Lifesciences Limited on 6ix

Earlier from iSERA Lifesciences

Later from iSERA Lifesciences

All iSERA Lifesciences news releases